Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality

Ischemic stroke accounts for about 87% of all strokes, causing long-term disability in adults, and is the second leading cause of death worldwide. In search of new therapeutic modalities, the use of neuroprotective agents loaded in nanocarriers to be delivered by noninvasive means (i.e. via intranas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bseiso, Eman A., AbdEl-Aal, Sarah A., Nasr, Maha, Sammour, Omaima A., El Gawad, Nabaweya A. Abd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341381/
https://www.ncbi.nlm.nih.gov/pubmed/35892291
http://dx.doi.org/10.1080/10717544.2022.2104405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341381/
https://www.ncbi.nlm.nih.gov/pubmed/35892291
http://dx.doi.org/10.1080/10717544.2022.2104405

Ejemplares similares